Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-10-14 | New | $397,000 | $397,000 | Equity Only | 06b | SEC link |
| 2025-02-04 | New | $1,000,000 | $1,000,000 | Debt Only | 06b | SEC link |
| 2024-03-26 | New | $1,893,339 | $1,893,339 | Debt Only | 06b | SEC link |
| 2022-08-10 | Amended | $6,440,000 | $3,840,000 | Debt Only | 06b | SEC link |
| 2021-04-29 | Amended | $2,600,000 | $2,350,000 | Debt Only | 06b | SEC link |
| 2020-06-19 | New | $250,000 | $250,000 | Debt Only | 06b | SEC link |
| Name | Role |
|---|---|
| Nasim Annabi | Director |
| Jeffrey Behrens | Director, Executive |
| Michael Cima | Director |
| Max Cotler | Executive |
| Reza Dana | Director |
| Arthur Driscoll | Director, Executive |
| Parinaz Motamedy | Director |